Fortis Therapeutics Company
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.
Technology:
Neurological Disorders
Industry:
PharmTech
Headquarters:
La Jolla, California, United States
Founded Date:
2016
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership